NCT06863727 The Beijing Longitudinal Disability Survey in Community Elderly
| NCT ID | NCT06863727 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Xuanwu Hospital, Beijing |
| Condition | Ageing |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,962 participants |
| Start Date | 2023-08-07 |
| Primary Completion | 2028-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,962 participants in total. It began in 2023-08-07 with a primary completion date of 2028-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to establish the prospective cohort of the Beijing Longitudinal Disability Survey in Community Elderly (BLINDSCE) to explore the high-risk factors and preventive interventions for disability and cognitive impairment among community-dwelling adults aged 65 years and over. The main question it aims to answer is: * What are the high-risk factors able to predict the incidence and advance of disability and cognitive impairment in community-dwelling adults aged 65 years and over? * What are the categories of function and cognitive performance trajectory in community-dwelling adults aged 65 years and over?
Eligibility Criteria
Inclusion Criteria: * Community-dwelling adults aged 65 years or older who reside in Beijing. * Participants who sign an institutionally approved informed consent. Exclusion Criteria: * Participants with severe mental disorders and serious medical conditions preventing study investigation * Participants undergoing long-term professional treatment for physical function and cognitive functioning, such as hospitalization or rehabilitation.
Contact & Investigator
Yansu Guo, Ph.D
PRINCIPAL INVESTIGATOR
Beijing Geriatric Healthcare and Disease Prevention Center, Xuanwu Hospital, Capital Medical University
Frequently Asked Questions
Who can join the NCT06863727 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Ageing. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06863727 currently recruiting?
Yes, NCT06863727 is actively recruiting participants. Contact the research team at gys188@163.com for enrollment information.
Where is the NCT06863727 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06863727 clinical trial?
NCT06863727 is sponsored by Xuanwu Hospital, Beijing. The principal investigator is Yansu Guo, Ph.D at Beijing Geriatric Healthcare and Disease Prevention Center, Xuanwu Hospital, Capital Medical University. The trial plans to enroll 1,962 participants.